norovirus polymerase inhibitors (Cocrystal Pharma)

N/A

Report date: 2025/01/26 16:38:15
NME

Base Information

Drug Namenorovirus polymerase inhibitors (Cocrystal Pharma)
Drug Alias Namebroad-spectrum antivirals (Cocrystal Discovery)broad-spectrum antivirals (Biozone/Cocrystal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsNorovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCocrystal Discovery Inc
China Registration ClassN/A

Develop Information

Active CompaniesCocrystal Pharma Inc
Inactive CompaniesCocrystal Discovery Inc
Active IndicationsNorovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A